Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what assessment she has made of her Department's (a) capital investment exposure to, (b) potential capital spending requirements resulting from and (c) overall investment portfolio resilience from an equity price correction in US stock markets.

The Department for Science, Innovation and Technology (DSIT) does not hold any direct capital investments in companies listed on US equity markets.

DSIT’s capital portfolio consists of investments approved on a case‑by‑case basis against agreed criteria, and is primarily focused on UK‑based research, innovation and infrastructure programmes, as well as government‑sponsored bodies. DSIT's investments are monitored on a portfolio basis, including assessing market and valuation risks and considering any indirect effects global market movements on the Department’s assets.